<?xml version="1.0"?>
<Articles JournalTitle="Iranian Journal of Allergy, Asthma and Immunology">
  <Article>
    <Journal>
      <PublisherName>Tehran University of Medical Sciences</PublisherName>
      <JournalTitle>Iranian Journal of Allergy, Asthma and Immunology</JournalTitle>
      <Issn>1735-1502</Issn>
      <Volume>0</Volume>
      <Issue>0</Issue>
      <PubDate PubStatus="epublish">
        <Year>2025</Year>
        <Month>12</Month>
        <Day>22</Day>
      </PubDate>
    </Journal>
    <title locale="en_US">The Role of Hyperthermia in Enhancing Anti-tumor Efficacy of Pemetrexed and Altering hsa-MiR-548c-3p Expression Profile in A549 Cell Line  (Human Lung Cancer)</title>
    <FirstPage>1</FirstPage>
    <LastPage>10</LastPage>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Sepideh</FirstName>
        <LastName>Mokabberi</LastName>
        <affiliation locale="en_US">Department of Molecular Cell Biology and Genetics, Bu.C., Islamic Azad University, Bushehr, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Nahid</FirstName>
        <LastName>Babaei</LastName>
        <affiliation locale="en_US">Department of Molecular Cell Biology and Genetics, Bu.C., Islamic Azad University, Bushehr, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Hadi</FirstName>
        <LastName>Esmaeili Gouvarchin Ghaleh</LastName>
        <affiliation locale="en_US">Applied Virology Research Center, Biomedicine Technologies Institute, Baqiyatallah University of Medical sciences, Tehran, Iran</affiliation>
      </Author>
      <Author>
        <FirstName>Gholamreza</FirstName>
        <LastName>Farnoosh</LastName>
        <affiliation locale="en_US">Applied Biotechnology Research Centre, New Health Technologies Institute, Baqiyatallah University of Medical Sciences, Tehran, Iran</affiliation>
      </Author>
    </AuthorList>
    <History>
      <PubDate PubStatus="received">
        <Year>2025</Year>
        <Month>04</Month>
        <Day>04</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2025</Year>
        <Month>09</Month>
        <Day>11</Day>
      </PubDate>
    </History>
    <abstract locale="en_US">Lung cancer remains a major cause of cancer-related mortality worldwide, with current treatments such as surgery, chemotherapy, and immunotherapy facing limitations, including severe side effects and high costs. Hyperthermia (H) has emerged as a promising strategy to enhance tumor sensitivity to treatments and reduce toxicity. This study investigates the effects of H in enhancing the anti-tumor efficacy of pemetrexed (PEM) and altering the expression profile of hsa-MiR-548c-3p (tumor suppressor) in the A549 cell line.
A549 cells were cultured in DMEM medium and divided into four groups: Control, and treatment with H, PEM, and a combination of H and PEM. Subsequently, cell viability, apoptosis percentage, release rate of LDH, production of ROS, and the expression level of hsa-MiR-548c-3p, CASP 8 and 9, and TYMS genes were measured.
Results revealed that the combination of H and PEM treatment had greater antitumor effects compared to the other groups. The combination of H and PEM significantly reduced cell viability, increased the percentage of apoptosis, LDH release, and ROS production, and upregulated hsa-MiR-548c-3p, CASP 8, and 9, while downregulating TYMS.
The findings suggest that H enhances the chemotherapeutic efficacy of PEM by upregulating hsa-MiR-548c-3p expression and promoting apoptosis in lung cancer cells, making it a promising complementary approach for overcoming drug resistance.</abstract>
    <web_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/view/4406</web_url>
    <pdf_url>https://ijaai.tums.ac.ir/index.php/ijaai/article/download/4406/2276</pdf_url>
  </Article>
</Articles>
